Is a complete EBR/OXUR research report available?

No complete published report is available for ebr/OXUR (EBR/OXUR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

EBR/OXUR (EBR/OXUR)

Euronext Brussels: EBR/OXUR · EUR

€0.00

-0.00 (-14.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-02 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first EBR/OXUR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	212.9K
Revenue (ttm)	555K
Net income (ttm)	-3.7M
EPS (ttm)	-€0.13
Shares out	88.7M
Volume	192,000
Beta	-0.11

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 555K
Net income (ttm): -3.7M
EPS (ttm): -€0.13
Market cap: 212.9K

All EBR/OXUR indicators

Market & fundamental data

Available fields

178

Groups with data

Currency

EUR

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Belgium
Country code	BE
Employees	26
Employees Change	15%
Employees Change Percent	136.4
Enterprise value	EUR 11.4M
Exchange	Euronext Brussels
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Industry PE	25.92
Isin	BE0003846632
Last refreshed	2026-08-02
Market cap	EUR 212,859
Price	EUR 0
Price currency	EUR
Rev Per Employee	21,346.15x
Sector	Healthcare
Sector PE	26.77
Sector PE Fwd	22.64
Sic	2836
Symbol	ebr/OXUR
Website	https://www.oxurion.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1,751.39%
EV/Sales	20.59x
FCF yield	-801%
P/B ratio	-0.02x
P/S ratio	0.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-592.97%
EBITDA Margin	-580.72%
Gross margin	100%
Gross Profit	EUR 555,000
Gross Profit Growth3 Y	89.16%
Gross Profit Growth5 Y	-18.34%
Net Income	EUR -3.7M
Net Income Growth Years	0%
Pretax Margin	-666.31%
Profit Per Employee	EUR -143,385
ROA	-43.21
Roa5y	-54.66
ROCE	26.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-80.52%
Cagr15y	-70.01%
Cagr1y	-92.83%
Cagr20y	-56.92%
Cagr3y	-94.68%
Cagr5y	-95.96%
EPS Growth Years	0
Revenue Growth	18,400x
Revenue Growth Q	27,650x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	-2.29x
Revenue Growth5 Y	-23.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.12
Assets	EUR 3.8M
Cash	EUR 430,000
Current Assets	EUR 1.8M
Current Liabilities	EUR 16.2M
Debt	EUR 11.4M
Debt FCF	EUR -6.71
Equity	EUR -12.7M
Interest Coverage	-28.13
Liabilities	EUR 16.5M
Long Term Assets	EUR 2M
Long Term Liabilities	EUR 336,000
Net Cash	EUR -11M
Net Cash By Market Cap	EUR -5,173
Tangible Book Value	EUR -13.6M
Tangible Book Value Per Share	EUR -0.22
WACC	0.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.11
Net Working Capital	EUR -3.4M
Quick ratio	0.11
Working Capital	EUR -14.4M
Working Capital Turnover	EUR -0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2,108.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-92.81%
200-day SMA	0.01
3Y total return	-99.99%
50-day SMA	0
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	478,200
All Time High Change	-100%
All Time High Date	2013-01-09
All Time Low	0
All Time Low Change	20%
All Time Low Date	2026-07-21
ATR	0
Beta	-0.11
Beta1y	0.43
Beta2y	0.65
Ch YTD	-66.67
High	0
High52	0.04
High52 Date	2025-08-05
High52ch	-93.88%
Low	0
Low52	0
Low52 Date	2026-07-21
Low52ch	20%
Ma50ch	-20%
Price vs 200-day SMA	-61.9%
RSI	41.38
RSI Monthly	21.58
RSI Weekly	24.4
Sharpe ratio	-1.95x
Sortino ratio	-2.61
Total Return	-2,108.21%
Tr YTD	-66.67
Tr15y	-100%
Tr1m	-14.29%
Tr1w	-7.69%
Tr3m	-36.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -3.3M
Operating margin	-593

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	87,442,219%
Net Borrowing	1,720,000
Shares Institutions	0.92%
Shares Out	88,691,312
Shares Qo Q	933.4%
Shares Yo Y	2,108.21%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	748,506.4x
Bv Per Share	-0.21
Ch10y	-100
Ch15y	-100
Ch1m	-14.29
Ch1w	-7.69
Ch1y	-92.81
Ch20y	-100
Ch3m	-36.84
Ch3y	-99.99
Ch5y	-100
Ch6m	-64.71
Change	-14.29%
Change From Open	0
Close	0
Days Gap	-14.29
Depreciation Amortization	36,000
Dollar Volume	460.8
Earnings Date	2026-09-30
EBIT	EUR -3.3M
EBITDA	EUR -3.2M
EPS	EUR -0.13
F Score	2
FCF	EUR -1.7M
FCF EV Yield	-14.92x
FCF Per Share	EUR -0.02
Financing CF	1,951,000
Fiscal Year End	December
Founded	1,991
Goodwill	182,000
Income Tax	EUR 10,000
Investing CF	-270,000
Is Primary Listing	1
Last Earnings Date	2026-04-03
Last Report Date	2025-12-31
Last Split Date	2024-09-03
Last Split Type	Reverse
Ma150	0
Ma150ch	-48.94%
Ma20	0
Ma20ch	-7.69%
Net CF	-25,000
Next Earnings Date	2026-09-30
Open	0
Position In Range	0
Ppne	154,000
Price Date	2026-07-31
Relative Volume	0.26x
Revenue	555,000x
Tax By Revenue	1.8x
Tr20y	-100%
Tr6m	-64.71%
Volume	192,000
Z Score	-49.33

EBR/OXUR (EBR/OXUR)

Coverage state: Market snapshot only — no published research

Generate the first EBR/OXUR analysis

Price

Financial snapshot

Fair-value bridge

Latest news · EBR/OXUR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBR/OXUR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on EBR/OXUR

Frequently asked questions